<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Jinlai Wei</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0016241000</full_dataset_link><submitter_email>weilai03109@163.com</submitter_email><submitter_affiliation>the First Affiliated Hospital of Chongqing Medical University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Usnic Acid Inhibits Colorectal Cancer Liver Metastasis by Targeting CRYAB Phosphorylation and Inducing Ferroptosis</name><description>Here we report that CRYAB phosphorylation serves as a key driver of colorectal cancer liver metastatic progression, and establish usnic acid as an anti-metastatic compound that functions by targeting this post-translational modification. Mechanistically, beyond its canonical pro-apoptotic activity, usnic acid induces ferroptosis through the selective inhibition of CRYAB phosphorylation at serine 59. These findings provide a mechanistic foundation for the development of usnic acid as a potential therapeutic agent for metastatic colorectal cancer, and emphasize the clinical potential of targeting CRYAB phosphorylation and ferroptosis in the management of colorectal cancer liver metastases.</description><dates><publication>Wed Mar 18 00:00:00 GMT 2026</publication></dates><accession>PXD075824</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>